FOCUS(301283)
Search documents
聚胶股份(301283) - 关于变更注册资本、经营范围、调整组织架构、修订公司章程及修订、制定部分制度的公告
2025-11-17 10:46
证券代码:301283 证券简称:聚胶股份 公告编号:2025-063 聚胶新材料股份有限公司 关于变更注册资本、经营范围、调整组织架构、 修订《公司章程》及修订、制定部分制度的公告 聚胶新材料股份有限公司(以下简称"公司"或"聚胶股份")于 2025 年 11 月 17 日召开第二届董事会第二十次会议,审议通过了《关于调整公司组织架 构的议案》《关于变更公司注册资本、经营范围及修订<公司章程>的议案》《关 于修订、制定公司部分制度的议案》,上述部分议案尚需提交公司 2025 年第二 次临时股东大会审议,现将有关事宜公告如下: 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、公司注册资本变更情况 由于公司已办理完成 2023 年限制性股票激励计划首次授予部分第一个归属 期的股份归属工作,41.7822 万股归属股票已于 2025 年 5 月 19 日上市流通。公 司总股本已由 8,000 万股增加至 8,041.7822 万股,注册资本将由 8,000 万元增加 至 8,041.7822 万元。 二、公司经营范围变更情况 根据公司实际经营及业务发展需要,公 ...
聚胶股份(301283) - 关于预计2026年开展金融衍生品套期保值交易业务的公告
2025-11-17 10:46
证券代码:301283 证券简称:聚胶股份 公告编号:2025-061 聚胶新材料股份有限公司 关于预计 2026 年开展金融衍生品套期保值交易业务 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 5、特别风险提示:公司拟开展的金融衍生品套期保值交易业务将遵循合法、 谨慎、安全和有效的原则,不从事以投机为目的的金融衍生品交易,但同时也会 存在一定的市场风险、违约风险、内部控制风险、法律风险等。 敬请投资者充分关注投资风险,理性投资。 一、交易业务情况概述 1、投资目的:公司在日常经营过程中涉及外币业务,进出口业务的主要结 算币种是美元、欧元等。受国际政治、经济等综合因素影响,外汇市场波动明显, 为有效应对汇率波动带来的风险,防范汇率大幅波动对公司经营造成重大不利影 响,公司拟通过金融衍生品套期保值交易进行汇率风险管理,开展的金融衍生品 交易均以套期保值、规避和防范汇率风险为目的,不进行单纯以盈利为目的的金 融衍生品交易。 2、交易额度和额度使用期限:公司拟开展的金融衍生品套期保值交易业务 额度为不超过 5 亿元人民币或等值外币,额度使用期限自 2026 ...
聚胶股份(301283) - 关于召开2025年第二次临时股东大会的通知
2025-11-17 10:45
证券代码:301283 证券简称:聚胶股份 公告编号:2025-064 聚胶新材料股份有限公司 关于召开 2025 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 聚胶新材料股份有限公司(以下简称"公司"或"本公司")于 2025 年 11 月 17 日召开第二届董事会第二十次会议,审议通过了《关于提议召开公司 2025 年 第二次临时股东大会的议案》,定于 2025 年 12 月 4 日(星期四)下午 14:30 召 开公司 2025 年第二次临时股东大会(以下简称"本次会议"或"会议")。现将本 次会议有关事宜通知如下: 一、会议召开基本情况 (一)股东大会届次:2025 年第二次临时股东大会 (二)召集人:董事会 (三)本次股东大会的召开符合有关法律、行政法规、部门规章、规范性文 件和《聚胶新材料股份有限公司章程》(以下简称"《公司章程》")等规定。 1、现场投票:包括股东本人出席现场会议或者通过填写授权委托书授权他 人出席现场会议(授权委托书详见附件一)。 2、网络投票:公司将通过深圳证券交易所交易系统和互联网投票系统 1 ...
聚胶股份(301283) - 第二届监事会第二十次会议决议公告
2025-11-17 10:45
证券代码:301283 证券简称:聚胶股份 公告编号:2025-057 一、监事会会议召开情况 聚胶新材料股份有限公司(以下简称"公司")第二届监事会第二十次会议(以 下简称"本次会议")于 2025 年 11 月 17 日在公司会议室以通讯方式召开。本次 会议的通知于 2025 年 11 月 12 日以电子邮件方式向全体监事发出。本次会议应 出席监事 3 人,实际出席监事 3 人。本次会议由监事会主席何少玲女士主持,公 司董事会秘书廖燕桃女士列席了本次会议。 本次会议的召集、召开方式和程序符合《中华人民共和国公司法》(以下简 称"《公司法》")等法律法规、规范性文件和《聚胶新材料股份有限公司章程》 (以下简称"《公司章程》")的规定。 二、监事会会议审议情况 1、审议通过《关于使用部分闲置自有资金和闲置募集资金进行现金管理的 议案》 经审核,公司监事会认为:本次拟使用不超过人民币 120,000 万元(含本数) (或等值外币)的闲置自有资金和不超过人民币 15,000 万元(含本数)(或等值 外币)闲置募集资金(含超募资金)进行现金管理,符合《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律 ...
聚胶股份(301283) - 第二届董事会第二十次会议决议公告
2025-11-17 10:45
证券代码:301283 证券简称:聚胶股份 公告编号:2025-056 聚胶新材料股份有限公司 第二届董事会第二十次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 聚胶新材料股份有限公司(以下简称"公司")第二届董事会第二十次会议 (以下简称"本次会议")于 2025 年 11 月 17 日在公司会议室以现场结合通讯方 式召开。本次会议的通知于 2025 年 11 月 12 日以电子邮件方式向公司全体董事 发出。本次会议应出席董事 9 人,实际出席 9 人(其中:刘青生先生、沃金业先 生、周明亮先生、逄万有先生、Sui Martin Lin 先生、罗晓光先生、葛光锐女士 以通讯表决方式出席本次会议)。本次会议由董事长陈曙光先生主持,公司监事 及高级管理人员列席了会议。 经审议,董事会同意公司(包含纳入合并范围内的子公司、孙公司)在确保 不影响募集资金投资项目建设、不影响公司正常生产经营及确保资金安全的情况 下,使用不超过人民币 120,000 万元(含本数)(或等值外币)的闲置自有资金 和不超过人民币 15,000 万元( ...
破发股聚胶股份董事拟减持 2022年上市超募4.8亿
Zhong Guo Jing Ji Wang· 2025-11-13 03:03
Core Viewpoint - The announcement of share reduction plans by directors of JuJiao Co., Ltd. indicates potential changes in shareholder structure and market sentiment towards the company [1][2]. Share Reduction Plans - Director Wo Jinye plans to reduce his holdings by up to 7,100 shares, representing 0.01% of the total share capital, within three months after the announcement [1]. - Shareholder Zheng Chaoyang intends to reduce his holdings by up to 2,412,534 shares, which is 3.00% of the total share capital, through both centralized bidding and block trading methods [1]. Shareholder Background - Zheng Chaoyang held 3,442,222 shares, accounting for 4.28% of the total share capital as of the announcement date [1]. - Zheng's initial holding was 5,848,100 shares, representing 7.31% of the total share capital, and he has cumulatively reduced his holdings by 2,405,900 shares, realizing approximately 68.02 million yuan [2]. Historical Share Performance - The stock price of JuJiao Co., Ltd. was reported at 41.41 yuan per share on September 24, 2023, leading to an estimated reduction amount of 99.90 million yuan for Zheng Chaoyang [2]. - The company went public on September 2, 2022, with an initial offering price of 52.69 yuan per share, but is currently trading below this price, indicating a state of underperformance [3]. Fundraising and Financials - JuJiao Co., Ltd. raised a total of 1,053.80 million yuan from its initial public offering, with a net amount of 962.20 million yuan after expenses [4]. - The total issuance costs amounted to approximately 91.60 million yuan, with underwriting fees constituting a significant portion of this amount [5].
11月12日增减持汇总:世纪华通增持 江波龙等18股减持(表)
Xin Lang Zheng Quan· 2025-11-12 13:50
Core Points - On November 12, Century Huatong announced a share repurchase plan of 500 million to 1 billion yuan for capital reduction [1][2] - A total of 18 A-share listed companies disclosed share reduction plans, indicating a trend of shareholder divestment [1][2] Summary of Share Repurchase - Century Huatong plans to repurchase shares worth between 500 million and 1 billion yuan to reduce registered capital [2] Summary of Share Reductions - Tai Xiang Co. plans to reduce no more than 1% of its shares by shareholder Zhongyuan Investment [2] - Jiang Bolong's second-largest shareholder has completed a reduction of 4.1915 million shares [2] - Senior management of Zhejiang Zhongcheng plans to reduce their holdings [2] - Controlling shareholder of Hexing Packaging intends to reduce no more than 1.91% of shares [2] - Shareholder Wang Ge of Dongfang Zhongke plans to reduce no more than 0.51% of shares [2] - Executive Yu Qingchi of Kuai Publishing plans to reduce no more than 0.02% of shares [2] - Directors and executives of Changlian Co. plan to collectively reduce no more than 0.77% of shares [2] - China Unicom's structural adjustment fund reduced 40.7003 million shares from November 10 to November 12 [2] - Shareholder Chen Bei of Ruimaite plans to reduce no more than 1.76% of shares [2] - Shareholder Zhang Hong of Aipeng Medical plans to reduce no more than 2% of shares [2] - Director Wo Jinye of Jujiao Co. plans to reduce no more than 0.01% of shares [2] - Directors and executives of Zhonglan Environmental Protection plan to reduce their holdings [2] - Shareholders Ning Kangqi and Beikangqi of Hendi Pharmaceutical plan to collectively reduce no more than 2.33% of shares [2] - Wuxi High-tech Zone New Momentum Industry Development Fund reduced 549,200 shares of Xiangnan Chip [2] - Controlling shareholder of Tianji Co. sold 8.4 million shares during a period of significant stock trading volatility [2] - The second-largest shareholder of Fangzheng Electric reduced a total of 1.6324 million shares on November 10 and 12 [2] - Controlling shareholder of Haodangjia plans to reduce no more than 2.7% of shares [2] - Controlling shareholder of Zhibang Home reduced 905,000 convertible bonds [2]
增减持公告汇总丨这家公司股东拟减持不超2.7%股份





Di Yi Cai Jing· 2025-11-12 12:42
Summary of Key Points Core Viewpoint - The article discusses various companies and their shareholders' intentions to buy or sell shares, indicating a trend of both increasing and decreasing shareholdings among different firms in the market [1]. Company Actions - 康缘药业's actual controller's concerted action party increased holdings by 80,000 shares [1]. - 好当家's controlling shareholder plans to reduce holdings by no more than 2.7% [1]. - 亨迪药业's shareholders, including 宁康企管, 倍康企管, and 雷小艳, intend to collectively reduce holdings by no more than 2.33% [1]. - 合兴包装's controlling shareholder 新疆兴汇聚 plans to reduce holdings by no more than 1.91% [1]. - 瑞迈特's shareholder 陈蓓 intends to reduce holdings by no more than 1.76% [1]. - 泰祥股份's 众远投资 plans to reduce holdings by no more than 1% [1]. - 香农芯创's 无锡高新区新动能产业发展基金 reduced holdings by 549,200 shares [1]. - 中国联通's structural adjustment fund will reduce holdings by 40,700,300 shares from November 10 to November 12 [1]. - 方正电机's shareholder 张敏 reduced holdings by 1,632,400 shares [1]. - 畅联股份's directors 徐峰 and 陈文晔 plan to reduce holdings by 0.57% and 0.20%, respectively [1]. - 中兰环保's shareholders 王广庆, 曹丽, and 李泉 plan to reduce holdings by 0.0375%, 0.2798%, and 0.0275%, respectively [1]. - 聚胶股份's director 沃金业 plans to reduce holdings by 0.01% [1]. - 浙江众成's executives 黄旭生 and 潘德祥 plan to reduce holdings by 0.0140% [1]. - 东方中科's shareholder 王戈 plans to reduce holdings by 0.51% [1]. - 海南瑞泽's vice president 于清池 plans to reduce holdings by no more than 0.02% [1].
聚胶股份(301283.SZ):董事沃金业拟减持不超过7100股
Ge Long Hui A P P· 2025-11-12 11:01
Core Viewpoint - The company JuJiao Co., Ltd. (301283.SZ) announced that its director, Mr. Wo Jinye, plans to reduce his shareholding by a maximum of 7,100 shares, which represents 0.01% of the company's total share capital, within three months after the announcement of this reduction plan [1] Summary by Relevant Sections - **Share Reduction Plan** - Mr. Wo Jinye intends to reduce his holdings through centralized bidding transactions [1] - The reduction will occur within three months following the announcement, excluding any periods prohibited by laws and regulations [1]
聚胶股份:董事沃金业拟减持不超0.01%股份
2 1 Shi Ji Jing Ji Bao Dao· 2025-11-12 10:39
Core Viewpoint - The announcement from JuJiao Co., Ltd. regarding the planned share reduction by director Wo Jinye highlights the company's ongoing management of shareholder equity and personal financial arrangements of its executives [1] Group 1: Share Reduction Plan - Director Wo Jinye plans to reduce his holdings by up to 7,100 shares, which represents 0.01% of the company's total equity, within a three-month period starting 15 trading days after the announcement [1] - The shares to be sold are from the company's 2023 restricted stock incentive plan, which have already vested [1] - The reduction period is set from December 4, 2025, to March 3, 2026, with the sale price determined by market conditions [1] Group 2: Impact on Company Governance - The share reduction will not lead to any change in the company's control or governance structure [1] - Wo Jinye is limited to transferring no more than 25% of his total shareholding each year during his tenure [1] - The planned reduction is framed as a personal financial arrangement, indicating no adverse effects on the company's ongoing operations [1]